跳至主要内容
临床试验/NCT04391712
NCT04391712已完成2 期

Multiwave Locked System (MLS) Laser Therapy for COVID-19 Positive Patients With Pulmonary Disease

Lowell General Hospital2 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2020年4月30日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
10
试验地点
2
主要终点
oxygenation

研究概览

简要总结

The aim of this study is to evaluate the effectiveness of MLS laser therapy as a treatment for pulmonary complications due to COVID-19 infection.

详细描述

Participants will be randomized into treatment vs. control group. Both groups will receive regular inpatient medical treatment. Participants in the experimental arm will receive laser treatments once daily for 4 days. Treatments will be delivered to the patients in a prone position using a 10 by 25 cm laser field across each lung with 7j/cm2 at 1500 Hz. Standard nursing protocols would be used to identify participant's pulmonary status throughout treatment.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • COVID-19 positive
  • Pulmonary compromise requiring oxygen support of approximately 2-6 liters
  • Able to self prone, or support in self-sitting position

排除标准

  • Ventilator management
  • Patients with autoimmune disorders or inflammatory conditions not related to COVID-19
  • Pregnant women

结局指标

主要结局

oxygenation

时间窗: Daily for 4 days

Patients oxygen requirements pulse oximetry will be evaluated for change from pre and post individual treatment as well as end of protocol

Chest Xray radiographic results

时间窗: 7 Days

Pre treatment CXR will be compared to post treatment CXR using the RALE CXR evaluation scale

PSI Score

时间窗: 7 days

The change in pretreatment and post treatment scores will be evaluated

CRP levels

时间窗: 7 days

The change in pretreatment and post treatment levels will be evaluated The change in pretreatment and post treatment levels will be evalutated

Brescia-COVID Respiratory Severity Scale

时间窗: 7 days

The change in pretreatment and post treatment BCRSS will be evaluated

IL-6 levels

时间窗: First four days of trial

The change in pre treatment levels and 24 hours post final treatment

SMART-COP Score

时间窗: 7 days

The change in pretreatment and post treatment scores will be evaluated

Patient Disposition Post treatment

时间窗: 7 days

ICU on vent, ICU not requiring ventilation, Discharge to Rehab requiring assistance, Discharge to Home unable to perform ADL's, Discharge to Home able to perform ADL's

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Scott Sigman, MD

Principal Investigator

Lowell General Hospital

研究点 (2)

Loading locations...

相似试验